REVIEW article
Front. Nutr.
Sec. Nutrition and Metabolism
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1635266
This article is part of the Research TopicHuman Milk, Nutrition and Infant Development, Volume IIView all 8 articles
Nervonic acid in infant nutrition: a forward-looking approach to enhancing neurodevelopmental outcomes
Provisionally accepted
- Checkerspot, Inc., Alameda, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Nervonic acid (24:1 n-9, NA) is a monounsaturated very long-chain fatty acid (VLCFA) that plays a fundamental role in brain development, particularly in the biosynthesis of sphingolipids and myelin sheaths. NA is present in minute amounts in human milk and despite its importance in neuronal function and cognitive development, there is currently no ingredient available for the fortification of infant nutrition products. However, recent advances in biotechnology have made it feasible to produce high NA containing oil through fermentation, presenting a significant opportunity to address this nutritional gap. This review explores the potential of NA fortification in infant nutrition products and its impact on neurodevelopment, with a specific focus on two populations: premature infants, who are at higher risk of neurodevelopmental impairments due to incomplete in utero myelination, and healthy term infants, who may experience enhanced cognitive development with improved dietary NA intake when consuming infant formula. By critically examining the scientific basis for NA supplementation, as well as the practical challenges and regulatory considerations associated with its implementation, this review aims at providing a forward-looking perspective on how this emerging ingredient could enhance infant nutrition and improve health outcomes.
Keywords: nervonic acid, infant nutrition, Myelination, milk-fat globule membranes, premature infants, Fermentation, Brain Development, Sphingolipids
Received: 26 May 2025; Accepted: 12 Jun 2025.
Copyright: © 2025 Destaillats, Oliveira, Rakitsky, Zhou and Parker. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Frederic Destaillats, Checkerspot, Inc., Alameda, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.